跳至主要内容
临床试验/NL-OMON49068
NL-OMON49068招募中4 期

The treatment of venous thromboembolism with edoxaban in patients with cirrhosis, a pharmacokinetic study. - HEPATO study

Tergooi ziekenhuizen0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age >18 years
  • - Child Pugh A or B cirrhosis as assessed by treating gastroenterologist
  • - A diagnosis of venous thromboembolism (deep vein thrombosis, pulmonary
  • embolism, portal vein thrombosis) radiologically confirmed with ultrasound,
  • CT-scan, or MRI-scan
  • - Treatment with edoxaban 60mg 1dd as per the treating gastroenterologist

排除标准

  • - Inability to provide informed conesent
  • - Active malignancy or infection
  • - Grade III/IV hepatic encephalopathy
  • - Cognitive disorders or other unfavorable conditions at discretion of treating

研究者

发起方
Tergooi ziekenhuizen

相似试验